HPV Vaccination Prevalence among Lebanese Female University Students: A Cross-Sectional Study

Table 4

Responses to questions about HPV vaccine knowledge by the study participants.

Variable		N (%)	Mean ± SD	Min	Max
The vaccine is divided into 3 doses over 6 months	Yes	188 (41.4)
	No	23 (5.1)
	Do not know	243 (53.5)
HPV vaccine can be given from the age of 9	Yes	154 (33.9)
	No	76 (16.7)
	Do not know	224 (49.3)
HPV vaccine can prevent oropharyngeal cancer	Yes	123 (27.1)
	No	55 (12.1)
	Do not know	276 (60.8)
HPV vaccine can prevent penile cancer	Yes	154 (57.9)
	No	37 (8.1)
	Do not know	263 (57.9)
HPV vaccine can prevent prostate cancer	Yes	90 (19.8)
	No	75 (16.5)
	Do not know	289 (63.7)
HPV vaccine can prevent anal cancer	Yes	151 (33.3)
	No	38 (8.4)
	Do not know	265 (58.4)
Is the vaccine more effective if given before first sexual intercourse?	Yes	206 (45.4)
	No	58 (12.8)
	Do not know	190 (41.9)
Persons who received all doses are fully immunized against cervical cancer?	Yes	58 (12.8)
	No	187 (41.2)
	Do not know	209 (46.0)
Persons who received all doses are fully immunized against HPV?	Yes	124 (27.3)
	No	127 (28)
	Do not know	203 (44.7)
Is it safe to have unprotected sex after HPV vaccination?	Yes	26 (5.7)
	No	306 (67.4)
	Do not know	122 (26.9)
Are HPV vaccine side effects limited to mild local reaction?	Yes	143 (31.5)
	No	41 (9)
	Do not know	270 (59.5)
Can HPV cause permanent health problems?	Yes	41 (9)
	No	195 (43)
	Do not know	218 (48)

SD: standard deviation. The correct answers are in bold.